KORU Medical Systems Q3 2026 earnings
Revenue grew 12.4% year-over-year to $31.4 million, but adjusted EBITDA margin contracted by 2.2 percentage points to 13.9%.
Headline numbers
| Metric | Actual | YoY | QoQ | 8-K location |
|---|---|---|---|---|
| Revenue | $31.4 million | +12.4% | +4.9% | Ex. 99.1, Financial Highlights |
| EPS (GAAP) | $0.03 | +0.01 | +0.01 | Ex. 99.1, Financial Highlights |
| EPS (adjusted) | $0.05 | +0.01 | +0.01 | Ex. 99.1, Financial Highlights |
| Net income | $2.1 million | +0.7 million | +0.7 million | Ex. 99.1, Financial Highlights |
| Adj. EBITDA | $4.4 million | +0.5 million | +0.2 million | Ex. 99.1, Financial Highlights |
| Adj. EBITDA margin | 13.9% | -2.2 pp | -0.5 pp | Ex. 99.1, Financial Highlights |
Revenue breakdown
| Segment | Actual | YoY | Share of revenue | Note |
|---|---|---|---|---|
| North America | $17.4 million | +13.7% | 55% | — |
| International | $14.0 million | +10.9% | 45% | — |
Margins and costs
- Gross margin 53.8% (prior 54.5%, change -0.7 pp)
- Operating expenses $14.4 million (+11.2% YoY)
- One-offs in the quarter Tax benefit of $0.3 million related to foreign tax credit carryforwards; Restructuring charges of $0.2 million
- Effective tax rate 20.0% (prior-year 20.0%, year-to-date 20.0%)
- Non-GAAP bridge Adds back stock-based compensation ($0.8 million) and restructuring charges ($0.2 million).
KPIs
| Metric | Actual | Prior quarter | Prior year | Change |
|---|---|---|---|---|
| Free cash flow | $2.8 million | $2.6 million | $2.5 million | +0.2 million |
| Days sales outstanding | 48 days | 49 days | 50 days | -1 day |
| Cash and cash equivalents | $25.4 million | $22.8 million | $21.9 million | +2.6 million |
Guidance
| Metric | Guide | Prior guide | Change |
|---|---|---|---|
| Revenue | $30.0 million - $32.0 million | $30.0 million - $32.0 million | — |
| Adjusted EBITDA | $3.5 million - $4.5 million | $3.5 million - $4.5 million | — |
What drove it
- Revenue story Revenue grew 12.4% year-over-year, driven by 13.7% growth in North America and 10.9% growth in International.
- EPS story Adjusted EPS increased by $0.01 year-over-year, driven by higher revenue and a lower tax rate.
- One-off check Tax benefit of $0.3 million related to foreign tax credit carryforwards and restructuring charges of $0.2 million.
The good
- Revenue growth of 12.4% year-over-year
- Adjusted EBITDA of $4.4 million
- Free cash flow of $2.8 million
The bad
- Adjusted EBITDA margin contracted by 2.2 percentage points year-over-year
- Operating expenses increased 11.2% year-over-year
The ugly
- none
Open questions
- What specific factors drove the 11.2% increase in operating expenses?
- Why did the adjusted EBITDA margin contract despite revenue growth?
Full release
KORU Medical Systems (KRMD) earnings release, November 10, 2026
Attachments
Seq Document Description
───────────────────────────────────────────────────────────────────────────────
2 ex_99-1.htm PRESS RELEASE, DATED NOVEMBER 10, 2026